ReviewFrontiers in pharmacology2021

Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases.

Yanhong Bu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.